Skip to content
Indian Liberals
Filter:

Tip: search runs across all languages; results are tokenised per-page using the document's lang attribute. Search inside the documents →

essay · position paper

Minute of Dissent tabled by Mr. M.R.Masani, M.P. and Mr. Dahyabhai V. Patel, M.P., to the Report of the Joint Select Committee on the Patents Bill

By Minoo Masani

Swatantra Party Parliamentary Office. · New Delhi

2 pages

Summary

This two-page minute of dissent argues that the Joint Select Committee’s reported Patents Bill would weaken the property rights and incentives needed for invention, research, industrial development, and technological progress. The authors defend the established rationale for patents: inventors and firms undertake substantial financial risks in research and in bringing products to commercial use, and a period of exclusivity provides the prospective reward that makes those risks worthwhile. They also argue that strong patent protection has accompanied rapid industrial and scientific development, citing the United States and the international exchange of patents as examples.

The dissent rejects special discrimination against inventions in particular industries, including medicines and drugs, and opposes shortening the patent term below sixteen years. It accepts that carefully designed restrictions may be justified where unrestricted patent operation harms the public interest, but insists that intervention should be determined case by case, with clear limits and adequate compensation. The authors conclude that several clauses of the Bill violate generally accepted patent principles and that, unless substantially amended, the Bill should not be enacted.

Key points

  • Patents are presented as compensation for the financial risks involved in research, invention, and commercial exploitation.
  • The dissent argues that patent protection promotes, rather than discourages, scientific, industrial, and technical development.
  • It rejects discrimination between inventions in different fields, including medicines and drugs.
  • It defends sixteen years as the minimum patent term and opposes shortening the period of validity.
  • It accepts narrowly tailored restrictions to protect the public interest, provided that limits are clear and patentees receive adequate compensation.
  • It argues that several clauses of the reported Bill violate accepted patent principles and would damage India’s economic advancement.
  • The authors conclude that the Bill should not be enacted without deletion and substantial modification of objectionable provisions.

Metadata and summary are AI-extracted from the source PDF and reviewed for editorial accuracy. The original work is available via the Read PDF tab above (where present); paragraph-level citation inside the PDF is deferred to a future engagement.

People in this work

Related across the archive